Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 3, 2013, Pages 231-233

  López Rojas, Rafael ^a   Smani, Younes ^a   Pachón, Jerónimo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acinetobacter baumannii; antimicrobial resistance; therapeutic alternatives; virulence factors

Indexed keywords

ACINETOBACTER INFECTION; BACTERIAL VIRULENCE; CONTROL STRATEGY; DRUG TARGETING; EDITORIAL; HOST RESISTANCE; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; QUORUM SENSING;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; VIRULENCE FACTORS;

EID: 84874619118     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.13.11     Document Type: Editorial

References (18)

1. Vila J, Pachón J. Therapeutic options for Acinetobacter baumannii infections: an update. Expert Opin. Pharmacother. 13(16), 2319-2336 (2012).
2. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit. Care 11(3), 134 (2007).
3. Boucher HW, Talbot GH, Bradley JS et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48(1), 1-12 (2009).
4. Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev. Anti. Infect. Ther. 6(3), 309-325 (2008).
5. Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21(5), 601-614 (2007).
6. McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 37(2), 130-155 (2012).
7. Thawal ND, Yele AB, Sahu PK, Chopade BA. Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii bioflm. Curr. Microbiol. 65(1), 66-72 (2012).
8. Nidadavolu P, Amor W, Tran PL, Dertien J, Colmer-Hamood JA, Hamood AN. Garlic ointment inhibits bioflm formation by bacterial pathogens from burn wounds. J. Med. Microbiol. 61(Pt 5), 662-671 (2012).
9. Sulemankhil I, Ganopolsky JG, Dieni CA, Dan A F, Jones ML, Prakash S. Prevention and treatment of virulent bacterial bioflms with an enzymatic nitric oxide-releasing dressing. Antimicrob. Agents Chemother. 56(12), 6095-6103 (2012).
10. Thompson RJ, Bobay BG, Stowe SD et al. Identifcation of BfmR, a response regulator involved in bioflm development, as a target for a 2-aminoimidazole- based antibioflm agent. Biochemistry 51(49), 9776-9778 (2012).
11. Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of bioflm associated protein (Bap). Microb. Pathog. 51(6), 402-406 (2011).
12. McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect. Immun. 79(1), 518-526 (2011).
13. Luo G, Lin L, Ibrahim AS et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS ONE 7(1), e29446 (2012).
14. Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect. Immun. 80(10), 3381-3388 (2012).
15. McConnell MJ, Rumbo C, Bou G, Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29(34), 5705-5710 (2011).
16. Antunes LC, Imperi F, Minandri F, Visca P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 56(11), 5961-5970 (2012).
17. Lin L, Tan B, Pantapalangkoor P et al. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating infammation and enhancing phagocytosis. MBio 3(5), e00312-12 (2012).
18. Badger J, Chie-Leon B, Logan C et al. Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68(Pt 12), 1477-1481 (2012).